Furthermore, XPO1 protein expression was examined in colorectal cancer cells treated with eltanexor, revealing a dose-dependent reduction with drug treatment (Fig. 2E and F; Supplementary Fig. S2C–S2F). The gene discussed is XPO1; the disease is colorectal cancer.